Skip to main content
. 2023 Oct 11;13(10):e074334. doi: 10.1136/bmjopen-2023-074334

Table 3.

Study type and location of decentralised clinical trials by study phase

Phase I Phase I/II Phase II Phase II/III Phase III Phase IV
n=13 (17.1%) n=2 (2.6%) n=21 (27.6%) n=3 (3.9%) n=10 (13.2%) n=27 (35.5%)
Study type Single-country trial 12 2 18 2 6 21
Single regional trial 1 3 4
Multiregional trial 1 4 2
Study location* North America 2 2
Canada 1 (1) 3 (1)
USA 7 2 15 2 (1) 3 (3) 13 (2)
Europe 1 1 2
Belarus (1)
Belgium 1 (2)
Bulgaria (1)
Denmark (1) (1)
Finland 1
France 1 (2) 1
Germany 1 (2) 1 (1)
Israel (1)
Italy (1)
Netherlands 1 (2)
Poland (1)
Rumania (1)
Russian Federation (2)
Spain (1) (1)
Sweden 2 1 (1)
Turkey (1)
Ukraine (1)
UK 1 1 (1) 1 (1)
Asia-Pacific
Australia 1 1 (2) (1)
India (1)
Korea, Republic (1) 1
Japan (1)
Taiwan (1)

*The number in parentheses indicates the number of multiregional studies.